Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 6 studies | 43% ± 29% |
Insufficient scRNA-seq data for expression of HAL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 16279.22 | 226 / 226 | 82% | 62.32 | 332 / 406 |
lung | 76% | 402.59 | 439 / 578 | 41% | 3.59 | 476 / 1155 |
spleen | 95% | 1324.07 | 230 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 4126.56 | 745 / 929 | 0% | 0 | 0 / 0 |
skin | 71% | 3968.25 | 1282 / 1809 | 8% | 1.53 | 38 / 472 |
pancreas | 8% | 45.22 | 25 / 328 | 24% | 0.83 | 42 / 178 |
ovary | 0% | 0 | 0 / 180 | 30% | 1.03 | 129 / 430 |
esophagus | 7% | 33.32 | 95 / 1445 | 22% | 0.96 | 40 / 183 |
uterus | 3% | 10.78 | 5 / 170 | 17% | 0.57 | 78 / 459 |
bladder | 5% | 14.48 | 1 / 21 | 15% | 0.80 | 76 / 504 |
stomach | 3% | 9.95 | 10 / 359 | 13% | 0.68 | 38 / 286 |
intestine | 3% | 8.88 | 26 / 966 | 10% | 0.27 | 55 / 527 |
adipose | 12% | 60.30 | 143 / 1204 | 0% | 0 | 0 / 0 |
breast | 2% | 6.90 | 8 / 459 | 10% | 0.38 | 113 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.28 | 2 / 29 |
kidney | 0% | 0 | 0 / 89 | 4% | 0.18 | 33 / 901 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
adrenal gland | 0% | 1.48 | 1 / 258 | 1% | 0.04 | 3 / 230 |
blood vessel | 1% | 6.28 | 17 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 5.08 | 10 / 861 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 1% | 0.02 | 8 / 705 |
prostate | 1% | 2.37 | 2 / 245 | 0% | 0 | 0 / 502 |
muscle | 0% | 0.86 | 2 / 803 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.00 | 1 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019556 | Biological process | L-histidine catabolic process to glutamate and formamide |
GO_0006548 | Biological process | L-histidine catabolic process |
GO_0019557 | Biological process | L-histidine catabolic process to glutamate and formate |
GO_0005829 | Cellular component | cytosol |
GO_0004397 | Molecular function | histidine ammonia-lyase activity |
Gene name | HAL |
Protein name | HAL protein (Histidine ammonia-lyase) Histidine ammonia-lyase Histidase (EC 4.3.1.3) Histidine ammonia-lyase (Histidase) (EC 4.3.1.3) |
Synonyms | HIS |
Description | |
Accessions | Q2PH59 Q2PH56 Q4VB95 ENST00000546999.5 ENST00000546579.1 F8W0V1 Q2PH60 Q2PH55 Q2PH58 Q2PH61 ENST00000261208.8 [P42357-1] P42357 Q2PH57 ENST00000548808.1 ENST00000538703.5 [P42357-2] H0YHB0 ENST00000552509.5 ENST00000544080.6 F8VNX0 ENST00000541929.5 [P42357-3] |